A. Bini

发表

Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis.

K. Mann, F. Schoen, B. Kudryk, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Selection of thrombin-binding aptamers by using computational approach for aptasensor application.

Marco Mascini, Marcello Mascini, Anthony P F Turner, 2011, Biosensors & bioelectronics.

COVID-19 and intestinal inflammation: Role of fecal calprotectin

A. Gasbarrini, M. Consalvo, M. Pompili, 2020, Digestive and Liver Disease.

Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Products in Atherosclerosis: Use of Monoclonal Antibodies

R. Mesa-Tejada, J. Fenoglio, B. Kudryk, 1989, Arteriosclerosis.

Expression of gC1q-R/p33 and its major ligands in human atherosclerotic lesions.

R. Colman, E. Peerschke, A. Gotlieb, 2004, Molecular immunology.

Fibrin and Its Derivatives in the Normal and Diseased Vessel Wall

B. Kudryk, A. Bini, 1992, Annals of the New York Academy of Sciences.

Thrombosis in atherogenesis.

A. Bini, K. Kaplan, 1989, Critical reviews in oncology/hematology.

Fibrinogen in Human Atherosclerosis

B. Kudryk, A. Bini, 1994, Annals of the New York Academy of Sciences.

Use of Monoclonal Antibodies to Fibrinogen, Fibrin and Fibrin(Ogen) Degradation Products in Atherosclerosis

B. Kudryk, A. Bini, 1991 .

Identification and distribution of fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis

A. Bini, 1989 .

Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions.

Y. Nemerson, E. Grabowski, A. Bini, 2002, Blood.

Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics.

T. Schaible, B. Kudryk, A. Bini, 1991, Biotechnology.

Polymerization of fibrinogen in murine bleomycin-induced lung injury.

M. Olman, E. Miller, A. Bini, 1996, The American journal of physiology.

Fibrin and the vessel wall.

J. Fenoglio, B. Kudryk, A. Bini, 1990, Advances in experimental medicine and biology.

Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).

D. Collen, H. Lijnen, B. van Hoef, 1998, Biochemistry.

Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.

Y. Itoh, B. Kudryk, H. Nagase, 1996, Biochemistry.

Piezoelectric biosensors for aptamer-protein interaction.

M. Mascini, S. Tombelli, M. Minunni, 2009, Methods in molecular biology.

Flow and antibody binding properties of hydrated fibrins prepared from plasma, platelet rich plasma and whole blood.

B. Kudryk, R. Procyk, A. Bini, 1994, Thrombosis research.

Haemostatic Variables in Uncomplicated Diabetic Children

G. Chiumello, M. Donati, L. Mussoni, 1980, Thrombosis and Haemostasis.

Platelet aggregation and antithrombin III levels in diabetic children.

G. de Gaetano, G. Chiumello, E. Corbella, 1979, Haemostasis.

Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patients.

G. Remuzzi, M. Donati, L. Mussoni, 1980, Journal of clinical pathology.

Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments.

B. Kudryk, A. Bini, J. Schnuer, 1999, Biochemistry.

Analytical performances of aptamer-based sensing for thrombin detection.

Sonia Centi, Sara Tombelli, Maria Minunni, 2007, Analytical chemistry.

Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.

R. Mesa-Tejada, J. Fenoglio, B. Kudryk, 1989, Laboratory investigation; a journal of technical methods and pathology.

Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions.

J. Fenoglio, A. Bini, K. Kaplan, 1987, Blood.

Affinity chromatography of soluble fibrin in human plasma on insolubilized fibrinogen and on fragment D from fibrinogen, non cross-linked or cross-linked fibrin.

N. Semeraro, D. Collen, A. Bini, 1978, Thrombosis research.

Measurement of plasmin-antiplasmin complex in plasma: a comparison of latex agglutination, latex agglutination inhibition and hemagglutination inhibition tests.

D. Collen, A. Bini, 1978, Thrombosis research.

Fibrinogen and fibrin in the arterial wall.

B. Kudryk, A. Bini, 1994, Thrombosis research.

Low Molecular Weight Fibrinogen Degradation Products Stimulate the Release of Growth Factors from Endothelial Cells

A. Bini, L. Witte, R. Lorenzet, 1992, Thrombosis and Haemostasis.

Development of an optical RNA-based aptasensor for C-reactive protein

S Tombelli, M. Mascini, S. Tombelli, 2008, Analytical and bioanalytical chemistry.

Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).

H. Lijnen, D. Collen, A. Bini, 1998, Biochemistry.

Monoclonal antibody designated T2G1 reacts with human fibrin beta-chain but not with the corresponding chain from mouse fibrin.

B. Kudryk, A. Bini, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Biosensors, Aptamers (Aptasensors)

M. Mascini, A. Turner, A. Bini, 2010 .